Lepidic Predominant Adenocarcinoma Gene Set

Dataset DisGeNET Gene-Disease Associations
Category disease or phenotype associations
Type disease
External Link https://www.disgenet.org/browser/0/1/0/C4049711
Similar Terms
Downloads & Tools

Genes

45 genes associated with the disease Lepidic Predominant Adenocarcinoma in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.

Symbol Name
AR androgen receptor
ARHGEF12 Rho guanine nucleotide exchange factor (GEF) 12
BAK1 BCL2-antagonist/killer 1
BCL2L1 BCL2-like 1
BECN1 beclin 1, autophagy related
CCL2 chemokine (C-C motif) ligand 2
CD34 CD34 molecule
CDH1 cadherin 1, type 1, E-cadherin (epithelial)
CLDN1 claudin 1
CLDN10 claudin 10
COL4A5 collagen, type IV, alpha 5
CXCL8 chemokine (C-X-C motif) ligand 8
EGFR epidermal growth factor receptor
ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2
EZR ezrin
FMNL2 formin-like 2
GJA1 gap junction protein, alpha 1, 43kDa
ICAM1 intercellular adhesion molecule 1
IL11 interleukin 11
KLF9 Kruppel-like factor 9
LPA lipoprotein, Lp(a)
LPAR1 lysophosphatidic acid receptor 1
LPAR2 lysophosphatidic acid receptor 2
LPAR3 lysophosphatidic acid receptor 3
LPAR4 lysophosphatidic acid receptor 4
LPAR5 lysophosphatidic acid receptor 5
LPAR6 lysophosphatidic acid receptor 6
MIA melanoma inhibitory activity
MUC1 mucin 1, cell surface associated
MUC6 mucin 6, oligomeric mucus/gel-forming
P2RX7 purinergic receptor P2X, ligand gated ion channel, 7
PDPN podoplanin
PITX2 paired-like homeodomain 2
PLA2G1B phospholipase A2, group IB (pancreas)
PLA2G2A phospholipase A2, group IIA (platelets, synovial fluid)
PLA2G6 phospholipase A2, group VI (cytosolic, calcium-independent)
PROM1 prominin 1
RET ret proto-oncogene
RGS19 regulator of G-protein signaling 19
SLC2A10 solute carrier family 2 (facilitated glucose transporter), member 10
SMG1 SMG1 phosphatidylinositol 3-kinase-related kinase
TP63 tumor protein p63
TTF1 transcription termination factor, RNA polymerase I
VEGFA vascular endothelial growth factor A
VEGFC vascular endothelial growth factor C